157 related articles for article (PubMed ID: 20811676)
1. Deguelin promotes apoptosis and inhibits angiogenesis of gastric cancer.
Lee H; Lee JH; Jung KH; Hong SS
Oncol Rep; 2010 Oct; 24(4):957-63. PubMed ID: 20811676
[TBL] [Abstract][Full Text] [Related]
2. Deguelin inhibits human hepatocellular carcinoma by antiangiogenesis and apoptosis.
Lee JH; Lee DH; Lee HS; Choi JS; Kim KW; Hong SS
Oncol Rep; 2008 Jul; 20(1):129-34. PubMed ID: 18575727
[TBL] [Abstract][Full Text] [Related]
3. Deguelin exerts anticancer activity of human gastric cancer MGC-803 and MKN-45 cells in vitro.
Kang W; Zheng X; Wang P; Guo S
Int J Mol Med; 2018 Jun; 41(6):3157-3166. PubMed ID: 29512685
[TBL] [Abstract][Full Text] [Related]
4. Deguelin, an Akt inhibitor, down-regulates NF-κB signaling and induces apoptosis in colon cancer cells and inhibits tumor growth in mice.
Kang HW; Kim JM; Cha MY; Jung HC; Song IS; Kim JS
Dig Dis Sci; 2012 Nov; 57(11):2873-82. PubMed ID: 22623043
[TBL] [Abstract][Full Text] [Related]
5. Effects of deguelin on the phosphatidylinositol 3-kinase/Akt pathway and apoptosis in premalignant human bronchial epithelial cells.
Chun KH; Kosmeder JW; Sun S; Pezzuto JM; Lotan R; Hong WK; Lee HY
J Natl Cancer Inst; 2003 Feb; 95(4):291-302. PubMed ID: 12591985
[TBL] [Abstract][Full Text] [Related]
6. Identification of novel antiangiogenic anticancer activities of deguelin targeting hypoxia-inducible factor-1 alpha.
Oh SH; Woo JK; Jin Q; Kang HJ; Jeong JW; Kim KW; Hong WK; Lee HY
Int J Cancer; 2008 Jan; 122(1):5-14. PubMed ID: 17764071
[TBL] [Abstract][Full Text] [Related]
7. Deguelin suppresses cell proliferation via the inhibition of survivin expression and STAT3 phosphorylation in HTLV-1-transformed T cells.
Ito S; Oyake T; Murai K; Ishida Y
Leuk Res; 2010 Mar; 34(3):352-7. PubMed ID: 19781773
[TBL] [Abstract][Full Text] [Related]
8. [Effect of deguelin on proliferation and apoptosis of lymphoma Daudi cells and its mechanism].
Liu HL; Chen Y; Cui GH; Wu QL; Chen WH; He J
Zhonghua Zhong Liu Za Zhi; 2007 Mar; 29(3):176-80. PubMed ID: 17649631
[TBL] [Abstract][Full Text] [Related]
9. Deguelin inhibits growth of breast cancer cells by modulating the expression of key members of the Wnt signaling pathway.
Murillo G; Peng X; Torres KE; Mehta RG
Cancer Prev Res (Phila); 2009 Nov; 2(11):942-50. PubMed ID: 19861542
[TBL] [Abstract][Full Text] [Related]
10. [Effects of deguelin on proliferation and apoptosis of MCF-7 breast cancer cells by phosphatidylinositol 3-kinase/Akt signaling pathway].
Chu ZH; Liang XH; Zhou XL; Huang RF; Zhan Qz; Jiang JW
Zhong Xi Yi Jie He Xue Bao; 2011 May; 9(5):533-8. PubMed ID: 21565140
[TBL] [Abstract][Full Text] [Related]
11. Anti-cancer effects of deguelin on human leukemia K562 and K562/ADM cells In Vitro.
Wu Q; Chen Y; Liu H; He J
J Huazhong Univ Sci Technolog Med Sci; 2007 Apr; 27(2):149-52. PubMed ID: 17497282
[TBL] [Abstract][Full Text] [Related]
12. Anticancer efficacy of deguelin in human prostate cancer cells targeting glycogen synthase kinase-3 β/β-catenin pathway.
Thamilselvan V; Menon M; Thamilselvan S
Int J Cancer; 2011 Dec; 129(12):2916-27. PubMed ID: 21472727
[TBL] [Abstract][Full Text] [Related]
13. Antitumor effects of deguelin on H460 human lung cancer cells in vitro and in vivo: Roles of apoptotic cell death and H460 tumor xenografts model.
Hsu YC; Chiang JH; Yu CS; Hsia TC; Wu RS; Lien JC; Lai KC; Yu FS; Chung JG
Environ Toxicol; 2017 Jan; 32(1):84-98. PubMed ID: 26592500
[TBL] [Abstract][Full Text] [Related]
14. Deguelin inhibits vasculogenic function of endothelial progenitor cells in tumor progression and metastasis via suppression of focal adhesion.
Nguyen MP; Lee D; Lee SH; Lee HE; Lee HY; Lee YM
Oncotarget; 2015 Jun; 6(18):16588-600. PubMed ID: 26078334
[TBL] [Abstract][Full Text] [Related]
15. Regulating expressions of cyclin D1, pRb, and anti-cancer effects of deguelin on human Burkitt's lymphoma Daudi cells in vitro.
Liu HL; Chen Y; Cui GH; Wu QL; He J
Acta Pharmacol Sin; 2005 Jul; 26(7):873-80. PubMed ID: 15960896
[TBL] [Abstract][Full Text] [Related]
16. Apoptosis induction by the natural product cancer chemopreventive agent deguelin is mediated through the inhibition of mitochondrial bioenergetics.
Hail N; Lotan R
Apoptosis; 2004 Jul; 9(4):437-47. PubMed ID: 15192326
[TBL] [Abstract][Full Text] [Related]
17. Deguelin targets multiple oncogenic signaling pathways to combat human malignancies.
Tuli HS; Mittal S; Loka M; Aggarwal V; Aggarwal D; Masurkar A; Kaur G; Varol M; Sak K; Kumar M; Sethi G; Bishayee A
Pharmacol Res; 2021 Apr; 166():105487. PubMed ID: 33581287
[TBL] [Abstract][Full Text] [Related]
18. DCT015, a new sorafenib derivate, inhibits tumor growth and angiogenesis in gastric cancer models.
Wang W; Wang H; Ni Y; Yao Z; Ye L; Tian J
Tumour Biol; 2016 Jul; 37(7):9221-32. PubMed ID: 26768619
[TBL] [Abstract][Full Text] [Related]
19. Deguelin, a selective silencer of the NPM1 mutant, potentiates apoptosis and induces differentiation in AML cells carrying the NPM1 mutation.
Yi S; Wen L; He J; Wang Y; Zhao F; Zhao J; Zhao Z; Cui G; Chen Y
Ann Hematol; 2015 Feb; 94(2):201-10. PubMed ID: 25242579
[TBL] [Abstract][Full Text] [Related]
20. CecropinXJ inhibits the proliferation of human gastric cancer BGC823 cells and induces cell death in vitro and in vivo.
Wu YL; Xia LJ; Li JY; Zhang FC
Int J Oncol; 2015 May; 46(5):2181-93. PubMed ID: 25826779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]